Cantargia
4,608 SEK -0,04 %1.287 investorer følger denne virksomhed
Cantargia is a pharmaceutical company. Today, there is specialization in the development of antibody drugs used in the treatment of leukemia and other cancers such as lung and pancreatic cancer. The company's objective is to develop, sell and license drug candidates to companies operating in the mentioned work area. The largest operations are in the Nordic market, with headquarters in Lund.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CANTA
Daglig lav / høj pris
4,592 / 4,654
SEK
Markedsværdi
769,48 mio. SEK
Aktieomsætning
128,31 t SEK
Volumen
28 t
Seneste videoer
Finanskalender
Delårsrapport
22.08.2023
Delårsrapport
10.11.2023
Årsrapport
22.02.2024
Viser Alle indholdstyper
